Bempedoic acid, a component of nexlizet, is indicated: ร‚โ‚ฌยข to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, or coronary รขโ‚ฌยฆ Is nexlizet right for you?

The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of nexlizet and nexletol, at an incidence of รขโ€ฐยฅ2% and 0. 5% greater than placebo รขโ‚ฌยฆ